Vincent Aurentz

2016

In 2016, Vincent Aurentz earned a total compensation of $1.1M as Executive Vice President and Chief Business Officer at Arena Pharmaceuticals.

Compensation breakdown

Non-Equity Incentive Plan$67,025
Option Awards$835,920
Salary$151,538
Other$55,678
Total$1,110,161

Aurentz received $835.9K in option awards, accounting for 75% of the total pay in 2016.

Aurentz also received $67K in non-equity incentive plan, $151.5K in salary and $55.7K in other compensation.

Rankings

In 2016, Vincent Aurentz's compensation ranked 7,732nd out of 14,075 executives tracked by ExecPay. In other words, Aurentz earned more than 45.1% of executives.

ClassificationRankingPercentile
All
7,732
out of 14,075
45th
Division
Manufacturing
2,931
out of 5,486
47th
Major group
Chemicals And Allied Products
965
out of 1,900
49th
Industry group
Drugs
749
out of 1,543
52nd
Industry
Pharmaceutical Preparations
594
out of 1,173
49th
Source: SEC filing on April 28, 2017.

Aurentz's colleagues

We found six more compensation records of executives who worked with Vincent Aurentz at Arena Pharmaceuticals in 2016.

2016

Amit Munshi

Arena Pharmaceuticals

Chief Executive Officer

2016

Dominic Behan

Arena Pharmaceuticals

Chief Scientific Officer

2016

Steven Spector

Arena Pharmaceuticals

General Counsel

2016

Kevin Lind

Arena Pharmaceuticals

Chief Financial Officer

2016

Craig Audet

Arena Pharmaceuticals

Former Senior Vice President, Operations and Head of Global Regulatory Affairs

2016

Harry Hixson

Arena Pharmaceuticals

Chief Executive Officer

In-depth

You may also like